contraindications for glp-1 to Antihyperglycemic Medications in Diabetic Complications Independent Nurse - GLP-1 and

Statements and products are not intended to diagnose, treat, cure, or prevent any disease.

They may even prescribe a non-stimulant ADHD medication, such as guanfacine or clonidine

S9A, GLP-1RA intervention was associated with increased nausea events when compared to placebo (OR = 5.33

Buie's bio

Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)